Seller assumes all responsibility for this listing.
Condition: Used - Excellent
Brand: CARL ZEISS
Model: Cirrus HD-OCT 5000
Zeiss Cirrus HD-OCT 5000
- Manufactured in 2013
- Single Private Practice Owner (Installed Less than 1 Year)
- Version 6.5
- Advanced RPE
- Anterior Segment
- Zeiss Power Table
Today, there’s a CIRRUS that can help a practice manage the challenges faced on a daily basis. The new CIRRUS HD-OCT models 5000 is specifically designed to deliver a carefully constructed set of sophisticated applications that build upon one another to deliver rapidly-evolving diagnostics for multiple patient populations. CIRRUS HD-OCT 5000 is the clinical powerhouse with FastTrac, and sophisticated analyses for the busy advanced care practice.
CIRRUS for Retinal Disease
With the new FastTrac retinal tracking system, precise macular thickness analyses, Fovea Finder, detailed layer maps and more than 100 B-scans at your disposal, CIRRUS provides the framework to comprehensively assess your patient’s retinal condition. CIRRUS data cubes are registered with data from prior visits after the scan is acquired. This enables side-by-side visualization of the same location on the retina for each visit. CIRRUS compares measurements from the current and prior visits to provide a thickness change map that helps you determine next steps for your patient. 3-D cubes and Advanced Visualization can be used for pre-operative planning for VRI disorders. For dry AMD, CIRRUS helps monitor pre-conversion patients today and prepare for tomorrow’s dry AMD therapy.
CIRRUS for Glaucoma
No other company offers a more complete suite of integrated glaucoma diagnostics. CIRRUS is the HFA's perfect companion for glaucoma management. Today's CIRRUS glaucoma applications include RNFL, ONH and angle assessment as well as the new Ganglion Cell Analysis (GCA). When ONH and RNFL status are indeterminate, GCA can sharpen the picture. With CIRRUS angle imaging and central corneal thickness measurements, you have the world’s standard-setting comprehensive tool for glaucoma structural assessment. Guided Progression Analysis (GPA) provides a powerful tool for determining change for RNFL and optic nerve head parameters.
The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If so, do not purchase this item unless you are an authorized purchaser. If the item is subject to FDA regulation, I will verify your status as an authorized purchaser of this item before shipping of the item. If you have questions about legal obligations regarding sales of medical devices, you should consult with the FDA's Center for Devices and Radiological Health: www.fda.gov/cdrh/industry/support/index.html